Advertisement
Screener

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements

2.7 / 5 stars · 63/118 Roast Me

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements of 0 shares for the 3-month period ending 2026-06-27, per its 10-Q filed 2026-08-05.

Financial Statements › Notes

us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements · last filed 2026-08-05

  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. incremental common shares attributable to dilutive effect of share-based payment arrangements for the quarter ending 2026-06-27 was 0.00 shares, a 100.00% decline year-over-year.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. incremental common shares attributable to dilutive effect of share-based payment arrangements for the quarter ending 2026-03-28 was 0.00 shares, a 100.00% decline year-over-year.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. incremental common shares attributable to dilutive effect of share-based payment arrangements for the quarter ending 2025-09-27 was 213.00K shares, a 12.70% increase year-over-year.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. incremental common shares attributable to dilutive effect of share-based payment arrangements for the quarter ending 2025-06-28 was 167.00K shares, a 43.39% decline year-over-year.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. incremental common shares attributable to dilutive effect of share-based payment arrangements for fiscal 2025 was 0.00 shares, a 100.00% decline from fiscal 2024.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. incremental common shares attributable to dilutive effect of share-based payment arrangements for fiscal 2024 was 248.00K shares, a 10.71% increase from fiscal 2023.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. incremental common shares attributable to dilutive effect of share-based payment arrangements for fiscal 2023 was 224.00K shares, a 54.19% decline from fiscal 2022.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. incremental common shares attributable to dilutive effect of share-based payment arrangements for fiscal 2022 was 489.00K shares, a 56.80% decline from fiscal 2021.
Period endIncremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements 3 monthIncremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements 3 month as first filedIncremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements 6 monthIncremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements 6 month as first filedIncremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements 9 monthIncremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements 9 month as first filedIncremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements 12 monthIncremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements 12 month as first filed
2026-06-270.00 shares
10-Q · filed 2026-08-05
0.00 shares
10-Q · filed 2026-08-05
2026-03-280.00 shares
10-Q · filed 2026-05-07
2025-12-270.00 shares
10-K · filed 2026-02-18
2025-09-27213.00K shares
10-Q · filed 2025-11-05
186.00K shares
10-Q · filed 2025-11-05
2025-06-28167.00K shares
10-Q · filed 2026-08-05
176.00K shares
10-Q · filed 2026-08-05
2025-03-29176.00K shares
10-Q · filed 2026-05-07
2024-12-28248.00K shares
10-K · filed 2026-02-18
2024-09-28189.00K shares
10-Q · filed 2025-11-05
252.00K shares
10-Q · filed 2025-11-05
2024-06-29295.00K shares
10-Q · filed 2025-08-06
316.00K shares
10-Q · filed 2025-08-06
2024-03-30405.00K shares
10-Q · filed 2025-05-07
2023-12-30224.00K shares
10-K · filed 2026-02-18
2023-09-30324.00K shares
10-Q · filed 2024-11-06
294.00K shares
10-Q · filed 2024-11-06
2023-07-01251.00K shares
10-Q · filed 2024-08-07
225.00K shares
10-Q · filed 2024-08-07
2023-04-01331.00K shares
10-Q · filed 2024-05-09
2022-12-31489.00K shares
10-K · filed 2025-02-19
2022-09-24413.00K shares
10-Q · filed 2023-11-08
507.00K shares
10-Q · filed 2023-11-08
2022-06-25460.00K shares
10-Q · filed 2023-08-09
561.00K shares
10-Q · filed 2023-08-09
2022-03-26685.00K shares
10-Q · filed 2023-05-11
2021-12-251.13M shares
10-K · filed 2024-02-14
2021-09-251.13M shares
10-Q · filed 2022-11-02
1.13M shares
10-Q · filed 2022-11-02
2021-06-261.04M shares
10-Q · filed 2022-08-03
1.09M shares
10-Q · filed 2022-08-03
2021-03-271.09M shares
10-Q · filed 2022-05-04
2020-12-261.06M shares
10-K · filed 2023-02-22
2020-09-26999.00K shares
10-Q · filed 2021-11-03
889.00K shares
10-Q · filed 2021-11-03
2020-06-27693.00K shares
10-Q · filed 2021-08-04
747.00K shares
10-Q · filed 2021-08-04
2020-03-28777.00K shares
10-Q · filed 2021-05-04
2019-12-28963.00K shares
10-K · filed 2022-02-16
2019-09-28897.00K shares
10-Q · filed 2020-10-29
945.00K shares
10-Q · filed 2020-10-29
2019-06-29890.00K shares
10-Q · filed 2020-08-05
984.00K shares
10-Q · filed 2020-08-05
2019-03-301.00M shares
10-Q · filed 2020-05-07
2018-12-291.07M shares
10-K · filed 2021-02-17
2018-09-291.02M shares
10-Q · filed 2019-11-06
1.02M shares
10-Q · filed 2019-11-06
2018-06-30845.00K shares
10-Q · filed 2019-07-31
974.00K shares
10-Q · filed 2019-07-31
2018-03-311.04M shares
10-Q · filed 2019-05-07
2017-12-301.08M shares
10-K · filed 2020-02-11
2017-09-30939.00K shares
10-Q · filed 2018-11-07
910.00K shares
10-Q · filed 2018-11-07
2017-07-01751.00K shares
10-Q · filed 2018-08-08
835.00K shares
10-Q · filed 2018-08-08
2017-04-01875.00K shares
10-Q · filed 2018-05-10
2016-12-31944.00K shares
10-K · filed 2019-02-13
2016-09-24874.00K shares
10-Q · filed 2017-11-09
884.00K shares
10-Q · filed 2017-11-09
2016-06-25858.00K shares
10-Q · filed 2017-08-09
939.00K shares
10-Q · filed 2017-08-09
2016-03-26975.00K shares
10-Q · filed 2017-05-10
2015-12-261.14M shares
10-K · filed 2018-02-13
47.63M shares
10-K · filed 2016-02-12
2015-09-26955.00K shares
10-Q · filed 2016-11-02
1.01M shares
10-Q · filed 2016-11-02
2015-06-27875.00K shares
10-Q · filed 2016-08-03
1.01M shares
10-Q · filed 2016-08-03
2015-03-281.10M shares
10-Q · filed 2016-05-04
2014-12-27931.00K shares
10-K · filed 2017-02-14
47.56M shares
10-K · filed 2015-02-17
2014-09-27862.00K shares
10-Q · filed 2015-11-04
861.69K shares
10-Q · filed 2014-10-30
883.00K shares
10-Q · filed 2015-11-04
883.01K shares
10-Q · filed 2014-10-30
2014-06-28742.00K shares
10-Q · filed 2015-07-30
742.48K shares
10-Q · filed 2014-08-07
893.00K shares
10-Q · filed 2015-07-30
893.01K shares
10-Q · filed 2014-08-07
2014-03-291.06M shares
10-Q · filed 2015-04-30
1.06M shares
10-Q · filed 2014-04-30
2013-12-2848.49M shares
10-K · filed 2016-02-12
749.15K shares
10-K · filed 2014-02-25
2013-09-28530.52K shares
10-Q · filed 2014-10-30
704.12K shares
10-Q · filed 2014-10-30
2013-06-29555.08K shares
10-Q · filed 2014-08-07
678.26K shares
10-Q · filed 2014-08-07
2013-03-30777.05K shares
10-Q · filed 2014-04-30
2012-12-2948.41M shares
10-K · filed 2015-02-17
494.19K shares
10-K · filed 2013-02-27
2012-09-29482.81K shares
10-Q · filed 2013-10-30
447.54K shares
10-Q · filed 2013-10-30
2012-06-30383.06K shares
10-Q · filed 2013-07-31
439.84K shares
10-Q · filed 2013-07-31
2012-03-31516.79K shares
10-Q · filed 2013-05-08
2011-12-31495.18K shares
10-K · filed 2014-02-25
2011-09-24448.90K shares
10-Q · filed 2012-11-01
566.87K shares
10-Q · filed 2012-11-01
2011-06-25689.01K shares
10-Q · filed 2012-08-07
687.17K shares
10-Q · filed 2012-08-07
2011-03-26659.79K shares
10-Q · filed 2012-05-04
2010-12-250.00 shares
10-K · filed 2013-02-27
2010-09-25549.86K shares
10-Q · filed 2011-11-02
2010-06-26584.67K shares
10-Q · filed 2011-08-03
635.48K shares
10-Q · filed 2011-08-03
2009-12-26267.65K shares
10-K · filed 2012-02-27

Similar stocks

Stock NameCountryMarket CapPE Ratio
Medpace Holdings, Inc. (MEDP)United States$17.316B30.09
INCYTE CORP (INCY)United States$24.855B13.14
Absci Corp (ABSI)United States$1.775B-14.92
OmniAb, Inc. (OABI)United States$0.698B-8.05
NRC HEALTH (NRC)United States$0.450B42.50
MAXCYTE, INC. (MXCT)United States$0.124B-3.68
bioAffinity Technologies, Inc. (BIAF)United States$0.063B
OneMedNet Corp (ONMD)$0.042B
iSpecimen Inc. (ISPC)United States$0.003B
FOXO TECHNOLOGIES INC. (FOXO)United States$0.000B-277.71